Skip to content
1 min left
0% read
Axiom Bio logo

Axiom Bio

Technology Company
San Francisco, California, USA
Founded 2024
23

Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models.

Share:

Axiom's Predictive Models

Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models. Our proprietary dataset includes more than 100,000 molecules tested in pooled primary human liver cells, tens of thousands of molecules with pharmacokinetic measurements, and thousands of molecules with curated clinical outcome data.

Axiom's AI models offer higher accuracy than advanced in vitro systems like 3D spheroids, deep mechanistic understanding which untangles mitochondrial toxicity, ER stress, ROS formation, cytotoxicity, and more, and precise risk assessment for any molecule at relevant clinical dosage and clinical exposure levels. Our models remove the need for costly physical experiments, giving more accurate and cheaper toxicity assessments, and empowering scientists to make better-informed decisions and bring safer drugs to the clinic.

Frequently Asked Questions About Axiom Bio

Axiom Bio is an infrastructure company. Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models.

Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models. Our proprietary dataset includes more than 100,000 molecules tested in pooled primary human liver cells, tens of thousands of molecules with pharmacokinetic measurements, and thousand.

Axiom Bio has been operating since 2024. You can verify their legitimacy through their official website and social media presence.

Axiom Bio operates in the infrastructure sector of the cryptocurrency industry. Compare Axiom Bio with other infrastructure companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Axiom Bio, research their track record (operating since 2024), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Axiom Bio is based in San Francisco, California, USA, has been operating since 2024. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Axiom Bio is based in San Francisco, California, USA, North America.

Axiom Bio was founded in 2024. The company currently has 23 employees.

Axiom Bio Details

Axiom Bio Tags

More About Axiom Bio

Work Model Details
Employees work from physical offices.

Latest from Academy

Buy Verge Now or Wait Until Privacy Regulations Shift

Buy Verge Now or Wait Until Privacy Regulations Shift

XVG is trading near a multi-month low at $0.004285, down 17.67% over the last month. The privacy coin space has already felt regulatory pressure with several exchanges facing government scrutiny. Verge's case is different though. Verge has compensated users with privacy options rather than forcing privacy features on them. As regulators continue to stack the deck against privacy coins, Verge's argument for usability may become even more attractive.

11m
Why AIOZ Network Keeps Outperforming While Other DePINs Bleed

Why AIOZ Network Keeps Outperforming While Other DePINs Bleed

DePIN overall has declined 40% of its total market cap Q4 2025 to Q1 2026. Filecoin is trading at a fraction of its 2021 all-time highs. Theta has plateaued in node growth. Livepeer's demand for transcoding services has stagnated. But one project has been hard to miss in a sea of moving targets: AIOZ Network has continued to hit product milestones, crossed over 30,000 nodes from more than 100 countries, and had Kova Network, NakamotoGames, and other projects integrate with its network.

9m
Celestia Built the Modular Stack and Nobody's Using It Yet

Celestia Built the Modular Stack and Nobody's Using It Yet

The dominant narrative around Celestia right now is generational infrastructure bet. Some modular blockchain scaling tech that will reprice when everyone finally figures it out. Reality paints a different picture. TIA is trading 98.6% below its all-time high of $20.85. Celestia is generating $43.73 per day in network fees. Over 50% of all data being committed to the protocol comes from one rollup. The disconnect between "could use it" and "do use it" is the core narrative for TIA right now.

9m